$7.68
+2.7%Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
Last Annual Value
5.12M
3-Year CAGR
2%
5-Year CAGR
10%
10-Year CAGR
24%
| Company | Other Non-Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Alphatec Holdings, Inc. NASDAQ:ATEC | 5.12M | 28.4% | 9.5% | 24.4% | |
![]() Adaptive Biotechnologies Corporation NASDAQ:ADPT | 1.21M | -43.0% | -16.7% | N/A | |
![]() Surgery Partners, Inc. NASDAQ:SGRY | 56.80M | -18.1% | -0.8% | 13.0% | |
![]() Heartflow, Inc. Common Stock NASDAQ:HTFL | 9.81M | 19.7% | N/A | N/A | |
![]() Legend Biotech Corporation NASDAQ:LEGN | 5.00M | -68.0% | -0.6% | N/A | |
![]() Cidara Therapeutics, Inc. NASDAQ:CDTX | 96.00K | -54.9% | -29.0% | -6.6% | |
![]() Disc Medicine, Inc. NASDAQ:IRON | 726.00K | 45.9% | 32.2% | N/A | |
![]() Scholar Rock Holding Corporation NASDAQ:SRRK | 7.04M | 36.8% | 34.1% | 34.6% | |
![]() IDEAYA Biosciences, Inc. NASDAQ:IDYA | 411.31M | 707.2% | 300.9% | N/A |
Continue your ATEC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.